Nadolol as a treatment for akathisia.
The authors present three cases of patients with neuroleptic-induced akathisia who were successfully treated with nadolol, a peripherally acting beta blocker. They discuss the potential implications of this finding.
Ratey
J J
JJ
Sorgi
P
P
Polakoff
S
S
D000328:Adult; D017109:Akathisia, Drug-Induced; D014150:Antipsychotic Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D009248:Nadolol; D011412:Propanolamines / Q000627:therapeutic use*; D011595:Psychomotor Agitation / Q000188:drug therapy / Q000523:psychology; D011618:Psychotic Disorders / Q000188:drug therapy; D012559:Schizophrenia / Q000188:drug therapy
D014150:Antipsychotic Agents; D011412:Propanolamines; D009248:Nadolol